what are the prevalence of MEN 1 components?
What are the factors influencing the prevalence?
Is there a genotype phenotype correlation?
What are the difference between endocrine tumor in MEN 1& sporadic tumors?
What is the relationship between prolactinoma & weight gain in our patient?